Dana-Farber Cancer Institute: Study Finds Care After Donor Stem Cell Transplant Can Be Safely Shared Between Transplant Centers and Local Oncologists
January 10, 2025
January 10, 2025
BOSTON, Massachusetts, Jan. 10 (TNSres) -- The Dana-Farber Cancer Institute issued the following news release:
Patients undergoing a donor stem-cell transplant for leukemia or other blood-related cancer require months of specialized follow-up care, traditionally delivered at the center where they received their transplant - often a serious challenge for those who live far away. A large clinical trial by Dana-Farber Cancer Institute investigators shows that patients can fare just as . . .
Patients undergoing a donor stem-cell transplant for leukemia or other blood-related cancer require months of specialized follow-up care, traditionally delivered at the center where they received their transplant - often a serious challenge for those who live far away. A large clinical trial by Dana-Farber Cancer Institute investigators shows that patients can fare just as . . .